Bacteremia in children with tumors or malignant diseases 1991-2000;Blódsýkingar barna med æxli og illkynja sjúkdóma 1991-2000

Laeknabladid

Volumn 94, Issue 7-8, 2008, Pages 531-539

  Alfredsdottir I H ^a   Thors, V S ^b   Gudnason, P ^a   Jonmundsson G ^a   Kristinsson, J R ^a   Jonsson O G ^a   Kristinsson, K G ^a   Haraldsson, A ^a  

^a Læknadeild Háskóla ^*  (Iceland)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bacteremia; Children; Malignant diseases

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; BACTEREMIA; CHILD; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; ICELAND; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MORTALITY; NEOPLASM; NEWBORN; PRESCHOOL CHILD; RADIOTHERAPY; RETROSPECTIVE STUDY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; ICELAND; INFANT; INFANT, NEWBORN; NEOPLASMS; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 51149101044     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Longo DL. Approach to the patient with cancer. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th ed. New York: he McGraw-Hill Companies, Inc; 2005. p. 435-441
2. Nachman JB, Abelson HT. Oncology. In: Behrman E, Kliegman R, editors. Nelson Essentials of Pediatrics. 4th ed. Philadelphia: W.B.Saunders Company; 2002: 645-669
3. Sausville EA, Longo DL. Principles of cancer treatment: surgery, chemotherapy and biologic therapy. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th ed. New York: The McGraw-Hill Companies, Inc.; 2005: 464-489
4. Allison AC. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000; 47: 63-83.
5. Kristinsson VH, Kristinsson JR, Jónmundsson GK, Jónsson OG, Thorsson AV, Haraldsson Á. Immunoglobulin Class and Subclass Concentrations After Treatment of Childhood Leukemia. Pediatric Hemato Oncol 2001; 18: 167-172
6. Shaw PJ. Suspected infection in children with cancer. J Antimicrobial Chemotherapy 2002; 49 Suppl 1: 63-67
7. Finberg R. Infections in Patiens with Cancer. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th ed. New York: The McGraw-Hill Companies, Inc.; 2005: 489-497
8. Auletta JJ, O'Riordan MA, Nieder ML. Infections in children with cancer: a continued need for the comprehensive physical examination. J Pediatric Hemato Oncol 1999; 21: 501-508
9. Urrea M, Rives S, Ofelia C, Navarro A, García JJ, Estella J. Nosocomial infections among pediatric hematology/ oncology patients: results of a prospective incidence study. Am J Infection Control 2004; 34: 205-208
10. Pizzo PA. Fever in Immunocompromised Patients. Current Concepts 1999; 341: 893-899
11. Blijlevens NMA, Donnelly JP, De Pauw BE. Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infection 2001; 7: 47-53.
12. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 2001; 19: 3415-3421
13. Dourd MC, Arlet G, Leverger G, et al. Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 1991; 17: 30-35
14. Pizzo PA. Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia. N Engl J Med 1993; 328: 1323-1332
15. Langley J, Gold R. Sepsis in febrile neutropenic children with cancer. Pediatr Infect Dis J 1988; 7: 34-37
16. Rosato AE, Tallent SM, Edmond MB, Bearman GML. Susceptibility of coagulase-negative staphylococcal nosocomial boodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter. Am J Infect Control 2004; 32 :486-488
17. Philpott DC, Georg RH. Central venous catheter-related septicaemia in peadiatric cancer patients. J Hosp Infection 1997; 36: 67-76.
18. Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Port-A-Cath infections in children with cancer. Eur J Cancer 2004; 40 (2452-8).
19. West DC, Marcin JP, Mawis R, He J, Nagle A, Dimand R. Children with cancer, fever, and treatment-induced neutropenia: risk factors associated with illness raquiring the administration of critical care therapies. Pediatr Emerg Care 2004; 20: 79-84.
20. Klastersky J. Empirical treatment of sepsis in neutropenic patients. Int J Antimicrobial Ag 2000; 16: 131-133
21. Cohen J, Brubn-Buisson C, Torres A, Jorgensen J. Diagnosis of infection in sepsis: An evidence-based review. Crit Care Med 2004; 32(11 (Suppl.)): 466-494
22. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737-1741
23. Chuang YY, Hung IJ, Yang CP, Jaing TH, Lin TY, Huang YC. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer. Pediatr Infect Dis J 2002; 21: 203-209
24. Kline RM, Baorto EP. Treatment of Pediatric Febrile Neutropenia in the Era of Vancomycin-Resistant Microbes. Pediatr Blood Cancer 2005; 44: 207-214
25. Haslam DB. Managing the child with fever and neutropenia in an era of increasing microbial resistance. J Pediatr 2002; 140: 5-7.
26. Ammann RA, Hirt A, Luthy AR, Aebi C. Identification of Children Presenting With Fever in Chemotherapy-Induced Neutropenia at Low Risk for Severe Bacterial Infection. Med Pediatr Oncol 2003; 41: 436-443
27. Rúnarsson G, Önundarson PT, Kristinsson KG, Jóhannsson GM, Björnsdóttir J, Magnússon S. Sýkingar sjúklinga med brátt hvítblædi og neutropeniu á Landspítalanum 1981-1991. Læknabladid 1992; 78(Fylgirit 21).
28. Gustafsson G, Langmark F, Wesenberg F, Lannering B, Heyman M, De Verdier B. Childhood Cancer in the Nordic Countries: Report on Epidemiologic and Therapeutic Results From Registries and Working Groups. NOPHO Annual Meeting; 2005; Lillehammer; 2005.
29. Árnason S, Thors VS, Gudnason P, Kristinsson KG, Haraldsson Á. Blódsýkingar barna á Íslandi 1994-2005. Læknabladid 2008; 94: 525-529
30. Blódmeinafrædi - Klínísk efnafrædi - Handbók B. Available from: URL: www4landspitaliis/lsh-ytrinsf/pages/ rabokbhtm. Maí 2005.
31. Pastura PSVC, Land MGP, Santoro-Lopes G. Predictive Model for the Length of Hospital Stay of Children With Hematologic Malignancies, Neutropenia, and Presumed Infection. J Pediatr Hematol Oncol 2004; 26: 813-816
32. Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumor necrosis factor receptor II. Brit J Haematol 2000; 111: 1093-1102
33. Abbas AAH, Fryer CJH, Paltiel C, et al. Factors Influencing Central Line Infections in Children With Acute Lymphoblastic Leukemia: Results of a Single Institutional Study. Pediatr Blood Cancer 2003; 42: 325-331